EP3252047
CRYSTALLINE FORMS OF 6-[2-(METHYLCARBAMOYL)PHENYLSULFANYL]-3-E-[2-(PYRIDIN-2-YL)ETHENYL]INDAZOLE SUITABLE FOR THE TREATMENT OF ABNORMAL CELL GROWTH IN MAMMALS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
25.3.2008EP published:
11.5.2022EP application number:
17168752.8
EPO information:
European Patent Register
Max expiry date:
24.3.2028
Title in English:
CRYSTALLINE FORMS OF 6-[2-(METHYLCARBAMOYL)PHENYLSULFANYL]-3-E-[2-(PYRIDIN-2-YL)ETHENYL]INDAZOLE SUITABLE FOR THE TREATMENT OF ABNORMAL CELL GROWTH IN MAMMALSLanguage of the patent:
English
Timeline
Today
25.3.2008EP application
11.5.2022EP Publication
Owner
Name:
Pfizer Products Inc.Address:
Eastern Point Road, Groton, CT 06340, US
Inventor
Name:
CAMPETA, Anthony, MichaelAddress:
Groton, CT 06340, US
Name:
CHEKAL, Brian, PatrickAddress:
Groton, CT 06340, US
Name:
MCLAUGHLING, Robert, WilliamAddress:
Groton, CT 06340, US
Name:
SINGER, Robert, AlanAddress:
Groton, CT 06340, US
Priority
Number:
910379 PDate:
5.4.2007Country:
US
Number:
976546 PDate:
1.10.2007Country:
US
Number:
31554Date:
26.2.2008Country:
US
Classification
Categories:
C07D 401/06, A61K 31/4439, A61P 35/00